GlassScriptPhysician profile
Haley Jane Brewer
NPI 1154044964
$3,139.60
in general payments reported to CMS, 2019-2025
25 companies · $92.60 in 2025
The $92.60 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $198 · 2023: $1,891 · 2024: $957 · 2025: $92.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,941.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $590.42 | 2022-2025 | |
| Amgen INC. | $566.78 | 2023-2024 | Repatha, Otezla, Prolia |
| Astrazeneca Pharmaceuticals LP | $236.18 | 2022-2024 | Farxiga, Fasenra, Airsupra |
| Lilly USA, LLC | $231.82 | 2022-2024 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $190.58 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $189.34 | 2022-2023 | |
| Novo Nordisk INC | $170.95 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Lundbeck LLC | $146.06 | 2022-2023 | Rexulti |
| Glaxosmithkline, LLC. | $145.96 | 2022-2023 | Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.58 | 2022-2024 | Jardiance, Synjardy |
| Esperion Therapeutics, INC. | $90.19 | 2023 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $74.88 | 2023 | Praluent, Evkeeza |
| Exact Sciences Corporation | $69.37 | 2023-2024 | Cologuard Collection Kit |
| Medical Device Business Services, INC. | $60.96 | 2025 | Stratafix |
| Janssen Pharmaceuticals, INC | $56.05 | 2023-2024 | Spravato, Xarelto |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.55 | 2023 | |
| Inspire Medical Systems, INC. | $28.12 | 2024 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $24.89 | 2022 | |
| Axsome Therapeutics, INC. | $19.14 | 2023 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $18.30 | 2023 | Trintellix |
| Paratek Pharmaceuticals, INC. | $15.73 | 2022 | |
| Antares Pharma, INC. | $15.55 | 2023 | Xyosted, Tlando, Nocdurna |
| Sanofi-Aventis U.S. LLC | $14.72 | 2023 | |
| Phathom Pharmaceuticals, INC. | $14.04 | 2024 | Voquezna |
| Phadia US INC. | $13.44 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.